Department of Microbiology, Fujita Health University School of Medicine, 1-98, Dengakugakubo, Kutsukake-cho, Toyoake, Aichi 470-1192, Japan.
Center for Infectious Disease Research, Fujita Health University, 1-98, Dengakugakubo, Kutsukake-cho, Toyoake, Aichi 470-1192, Japan.
J Med Chem. 2024 Aug 22;67(16):14175-14183. doi: 10.1021/acs.jmedchem.4c00983. Epub 2024 Jul 31.
Modification of the R1 and R2 side chain structures has been used as the main strategy to expand the spectrum of cephalosporins and impart resistance to hydrolysis by β-lactamases. These structural modifications also result in a wide range of plasma protein binding, especially with human serum albumin (HSA). Here, we determined the crystal structures of the HSA complexes with two clinically important cephalosporins, ceftriaxone and cefazolin, and evaluated the binding of cephalosporin to HSA by susceptibility testing and competitive binding assay. Ceftriaxone and cefazolin bind to subdomain IB of HSA, and their cephem core structures are recognized by Arg117 of HSA. Tyr161 of HSA changes its rotamer depending on the cephalosporin, resulting in alterations of the cavity shape occupied by the R2 side chain of cephalosporins. These findings provide structural insight into the mechanisms underlying the HSA binding of cephalosporins.
结构修饰是扩展头孢菌素抗菌谱和抵抗β-内酰胺酶水解的主要策略,其改变了头孢菌素的侧链结构。这些结构修饰还导致了广泛的血浆蛋白结合,尤其是与人体血清白蛋白(HSA)的结合。在这里,我们测定了两种临床上重要的头孢菌素,头孢曲松和头孢唑林与 HSA 的复合物的晶体结构,并通过药敏试验和竞争性结合试验评估了头孢菌素与 HSA 的结合。头孢曲松和头孢唑林结合到 HSA 的亚域 IB,其头孢烯核结构被 HSA 的 Arg117 识别。HSA 的 Tyr161 根据头孢菌素的不同而改变其构象,导致头孢菌素的 R2 侧链占据的腔形状发生变化。这些发现为头孢菌素与 HSA 结合的机制提供了结构上的见解。